What's happening
Writing a plain-English summary… Track this bill to get it by email.
Why it matters
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
Headline styles
Sponsors
No co-sponsors yet.
History
- Referred to insurance
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Requires that insurance companies provide coverage for surveillance tests for ovarian cancer of certain insured individuals
In Assembly Committee · Insurance · Sponsor Felix Ortiz
Full text
The text isn't available here yet. Check nysenate.gov.
Sponsor's memo
BILL NUMBER:S6604
Title of bill
An act to amend the insurance law, in relation to providing coverage for surveillance tests for ovarian cancer
Purpose or general idea of bill
To require insurers to cover surveillance tests for ovarian cancer for female insureds who are at risk for this type of cancer
Summary of specific provisions
Adds a new paragraph 29 to Subsection (i) of section 3216 of the insurance law. Adds a new paragraph 18 to Subsection (k) of section 3221 of the insurance law. Adds a new subsection (ii) to Section 4303 of the insurance law.
Paragraph 29, paragraph 18 and subsection (ii) all provide that every policy that provides medical, major medical or similar comprehensive type coverage shall provide coverage for surveillance tests for ovarian cancer for an insured who is at risk for ovarian cancer. An insured is deemed to be at risk if: she has a family history of one or more first degree relatives with ovarian cancer; three or more female relatives with breast cancer or nonpolyposis colorectal cancer; she tests positive for BRCA 1 or BRCA 2 mutations. Surveillance tests for ovarian cancer shall mean annual screening for ovarian cancer using: CA-125 serum tumor maker testing; transvaginal ultrasound; and pelvic examination.
Justification
Ovarian cancer gives no warning signs and is very difficult to detect. Early detection through surveillance tests and treatment are the keys to stopping this deadly disease.
Prior legislative history
2005/06 - A.9840 - Referred to Insurance 2007/08 - A.5931 - Referred to Insurance 2009/10 - A.6475 - Held in Insurance
Fiscal implications for state and local governments
Minimal.
Effective date
This act shall take effect immediately and shall apply to any policy issued, renewed, or modified after such effective date.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.